Please provide your email address to receive an email when new articles are posted on . There are approximately 500 full-time fellowship-trained neuro- ophthalmologists in the U.S. to care for a ...

Please provide your email address to receive an email when new articles are posted on . Neuro-ophthalmologists have a lighthearted attitude about the perception of their specialty because, for many ...

ALISO VIEJO, Calif., March 19, 2025 /PRNewswire/ — Terumo Neuro, a global leader in neurovascular innovation and a wholly owned subsidiary of Terumo Corporation, proudly marks the 15th anniversary of ...

A Tufts-led app delivers weekly creative prompts and virtual art therapy to help brain tumor patients cope with life-changing treatment, isolation and identity shifts.

ATLANTA, March 18, 2025 (GLOBE NEWSWIRE) -- Alzamend Neuro, Inc. (Nasdaq: ALZN) (“Alzamend”), a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of ...

DEFY Neuro Rehabilitation launches during Brain Injury Awareness Month with a mission to serve families and strengthen recovery ...

ATLANTA--(BUSINESS WIRE)--Alzamend Neuro, Inc. (Nasdaq: ALZN) (“Alzamend”), an early clinical-stage biopharmaceutical company focused on developing novel products for the treatment of ...

ATLANTA, March 25, 2025 (GLOBE NEWSWIRE) -- Alzamend Neuro, Inc. (ALZN) (Nasdaq: ALZN) (“Alzamend”), a clinical-stage biopharmaceutical company focused on developing novel products for the treatment ...

ATLANTA, March 11, 2025 (GLOBE NEWSWIRE) -- Alzamend Neuro, Inc. (ALZN) (Nasdaq: ALZN) (“Alzamend”), a clinical-stage biopharmaceutical company focused on developing novel products for the treatment ...

Head-to-head studies of AL001 versus a marketed lithium carbonate product will be conducted for comparisons of lithium blood and brain/brain-structure pharmacokinetics in Bipolar Disorder subjects ...